Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Kaiteng Guo"'
Autor:
Wenjing Yu, Yuehuai Hu, Zhiping Liu, Kaiteng Guo, Dinghu Ma, Mingxia Peng, Yuemei Wang, Jing Zhang, Xiaolei Zhang, Panxia Wang, Jiguo Zhang, Peiqing Liu, Jing Lu
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 13, Iss 12, Pp 4875-4892 (2023)
The clinical utilization of doxorubicin (Dox) in various malignancies is restrained by its major adverse effect: irreversible cardiomyopathy. Extensive studies have been done to explore the prevention of Dox cardiomyopathy. Currently, ferroptosis has
Externí odkaz:
https://doaj.org/article/1c1f1593a4424320ac3f2f286454d136
Autor:
Jing Lu, Jingyan Li, Yuehuai Hu, Zhen Guo, Duanping Sun, Panxia Wang, Kaiteng Guo, Dayue Darrel Duan, Si Gao, Jianmin Jiang, Junjian Wang, Peiqing Liu
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 9, Iss 4, Pp 782-793 (2019)
The clinical application of doxorubicin (DOX) in cancer chemotherapy is limited by its life-threatening cardiotoxic effects. Chrysophanol (CHR), an anthraquinone compound isolated from the rhizome of Rheum palmatum L., is considered to play a broad r
Externí odkaz:
https://doaj.org/article/c4b8a9e8f70847b399653776fb1ddc85
Autor:
Junjian Wang, Juan Shen, Panxia Wang, Luping Wang, Kaiteng Guo, Qianqian Wang, Jiyan Xie, Zhenzhen Li, Yuehuai Hu, Sidong Cai, Rui Lan, Jing Lu, Liying Liang, Peiqing Liu
Publikováno v:
Journal of Molecular and Cellular Cardiology. 133:125-137
The clinical application of doxorubicin (Dox) in cancer therapy is limited by its serious cardiotoxicity. Our previous studies and others have recognized that mitochondrial dysfunction is the common feature of Dox-induced cardiotoxicity. However, mec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c30e7795b61cd9918b2a1927ba257ecf
https://doi.org/10.1016/j.yjmcc.2019.06.005
https://doi.org/10.1016/j.yjmcc.2019.06.005
Autor:
Zhen Guo, Hong Li, Peiqing Liu, Liying Liang, Panxia Wang, Qianqian Wang, Kaiteng Guo, Rui Lan, Yalin Tu, Jing Lu
Publikováno v:
Journal of Cell Science.
The cancer clinical therapy of Doxorubicin (Dox) is limited by its life-threatening cardiotoxic effects. Dickkopf-1 (Dkk1), the founding member of Dkk family, is best studied and functions as an antagonist of canonical Wnt/β-catenin. Dkk1 is conside
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7df8af524833fad820da25d64e478076
https://doi.org/10.1242/jcs.228478
https://doi.org/10.1242/jcs.228478
Autor:
Zhen Guo, Yuehuai Hu, Peiqing Liu, Luping Wang, Zhenzhen Li, Zhuoming Li, Jingyan Li, Xiaolei Zhang, Sidong Cai, Panxia Wang, Wenwei Luo, Jing Lu, Minghui Wang, Kaiteng Guo, Junying Huang, Hui Gao
Publikováno v:
British Journal of Pharmacology.
Background and purpose Activation of PKC-ζ is closely linked to the pathogenesis of cardiac hypertrophy. PKC-ζ can be activated by certain lipid metabolites such as phosphatidylinositol (3,4,5)-trisphosphate and ceramide. However, its endogenous ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf02ad17fa888dc6842dcc395118e6ff
https://doi.org/10.1111/bph.14538
https://doi.org/10.1111/bph.14538
Autor:
Jingyan Li, Shuya Sun, Peiqing Liu, Jing Lu, Junjian Wang, Yuehuai Hu, Kaiteng Guo, Yiqiang Zhang, Panxia Wang, Zhen Guo, Qiyao Zheng, Jianmin Jiang
Publikováno v:
Archives of toxicology. 93(2)
Doxorubicin (Dox) is an effective anticancer drug, however, its clinical application is restricted by the life-threatening cardiotoxic effects. Secreted Frizzled-related protein 1 (sFRP1) has been reported to participate in both the cancer and cardio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11ee204d61c7b767765b8cfba7b82254
https://pubmed.ncbi.nlm.nih.gov/30377735
https://pubmed.ncbi.nlm.nih.gov/30377735
Autor:
Jingyan Li, Yuehuai Hu, Junjian Wang, Jing Lu, Si Gao, Dayue Darrel Duan, Kaiteng Guo, Peiqing Liu, Panxia Wang, Zhen Guo, Jianmin Jiang, Duanping Sun
Publikováno v:
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica B, Vol 9, Iss 4, Pp 782-793 (2019)
Acta Pharmaceutica Sinica B, Vol 9, Iss 4, Pp 782-793 (2019)
The clinical application of doxorubicin (DOX) in cancer chemotherapy is limited by its life-threatening cardiotoxic effects. Chrysophanol (CHR), an anthraquinone compound isolated from the rhizome of Rheum palmatum L., is considered to play a broad r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffb63edc3aa6a4e5b9730d700327df64
https://pubmed.ncbi.nlm.nih.gov/31384538
https://pubmed.ncbi.nlm.nih.gov/31384538
Autor:
Zhen Guo, Zhenzhen Li, Junjian Wang, Jiantao Ye, Jingyan Li, Jing Lu, Yao Zhong, Peiqing Liu, Panxia Wang, Kaiteng Guo
Publikováno v:
Molecular and cellular endocrinology. 477
Jumonji domain-containing protein D3 (JMJD3), a histone 3 lysine 27 (H3K27) demethylase, has been extensively studied for their participation in development, cellular physiology and a variety of diseases. However, its potential roles in cardiovascula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db8fc72c5740d485cb0a220480bcad6e
https://pubmed.ncbi.nlm.nih.gov/29753027
https://pubmed.ncbi.nlm.nih.gov/29753027
Autor:
Liying Liang, Yalin Tu, Jing Lu, Panxia Wang, Zhen Guo, Qianqian Wang, Kaiteng Guo, Rui Lan, Hong Li, Peiqing Liu
Publikováno v:
Journal of Cell Science; May2019, Vol. 132 Issue 10, p1-11, 11p
Autor:
Liying Liang, Yalin Tu, Jing Lu, Panxia Wang, Zhen Guo, Qianqian Wang, Kaiteng Guo, Rui Lan, Hong Li, Peiqing Liu
Publikováno v:
Journal of Cell Science; May2019, Vol. 132 Issue 9, p1-34, 34p